Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 222
-3
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?

Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Nutritional analysis of cold-climate perennial vegetables

Perennial vegetables are edible plants that regrow in the same place every year. They are a key component...

Backer Badge Funded